Genetic Test
1200
aHUS/DDD Genetic Evaluation
Coding regions and splice sites of the following genes are sequenced: CFH, CFI, MCP(CD46), THBD, C4BPA, C4BPB, CFB, C3, DGKE, ADAMTS13, CFHR1, CFHR3, CFHR4 and CFHR5. USA test status: This is a laboratory developed test (LDT).
4865
Autosomal Dominant Thrombocytopenia Panel
This panel is designed for detection of germline variants in 22 genes known to cause thrombocytopenia, specifically inherited in an autosomal dominant manner. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4880
Bernard-Soulier Syndrome Panel
This panel is designed for the detection of germline variants in 3 genes known to cause Bernard-Soulier syndrome. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
3850
C/c Genotyping
Genotyping for the Rh C and c antigen, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
4815
Coagulation Disorder Panel
This panel is designed for the detection of germline variants in 19 genes and one targeted variant known to cause coagulation disorders. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT). USA test status: This is a laboratory developed test (LDT).
4825
Comprehensive Bleeding Disorder Panel
This panel is designed for the detection of germline variants in 66 genes and one targeted variant by aCGH known to cause bleeding due to disorders of coagulation, platelet function, and/or hereditary hemorrhagic telangiectasia (HHT). It can be ordered as: Next Generation Sequencing (NGS) only*; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. (* Includes PLAU performed by aCGH). USA test status: This is a laboratory developed test (LDT).
4830
Comprehensive Platelet Disorder Panel
This panel is designed for the detection of germline variants in 63 genes known to cause platelet function disorders and/or inherited thrombocytopenia. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT). USA test status: This is a laboratory developed test (LDT).
4845
Congenital Neutropenia Panel
This panel is designed for detection of germline variants in 35 genes known to cause severe congenital neutropenia (SCN), including cyclic neutropenia, non-syndromic neutropenia and syndromic neutropenia with non-hematological manifestations. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4850
Custom Blood Disorder Panel
Sequence analysis of genes included in any Hematology Genetics panel can be ordered as a custom panel (2-10 genes), as dictated by the patient's clinical and laboratory phenotype. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
3870
Doa/Dob Genotyping
Genotyping for the Dombrock antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3852
E/e Genotyping
Genotyping for the Rh E and e antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
4250
Erythroid Chimerism
Monitor erythroid lineage chimerism in patients with sickle cell disease (SCD) following allogeneic bone marrow transplantation. Hemoglobin genotyping of donor and recipient can be done by Test#4624 Hemoglobin SC Mutation Analysis. Indicate on requisition Donor and Patient genotype. USA test status: This is a laboratory developed test (LDT).
1035
Factor V Leiden (G1691A)
This molecular test evaluates individuals for the germline Factor V Leiden variant (F5 c. 1601G7A, p.Arg534Gln; Legacy nomenclature G1691A), which is associated with an increased risk of venous thromboembolism. USA test status: This is a laboratory developed test (LDT).
1401
Factor VIII (F8) Intron 1 Inversion Analysis
F8 intron 1 Inversion Analysis is appropriate for individuals with a family history of severe hemophilia A known to be caused by this pathogenic variant. USA test status: This is a laboratory developed test (LDT).
1400
Factor VIII (F8) Intron 22 Inversion Analysis
F8 intron 22 Inversion Analysis is appropriate for individuals with a family history of severe hemophilia A known to be caused by this pathogenic variant. USA test status: This is a laboratory developed test (LDT).
1402
Factor VIII (F8) Inversion Analysis
Factor 8 (F8) inversion analysis evaluates both the intron 1 and intron 22 inversions, and is recommended only for males with severe hemophilia A, or females who have a family history of severe unknown type of hemophilia A, or females with low factor VIII levels who have no known family history of hemophilia. This assay is included in the Factor VIII (F8) severe HA Analysis-Reflex test. F8 variants other than inversions are not detected by this assay. USA test status: This is a laboratory developed test (LDT).
1403
Factor VIII (F8) Severe HA Analysis-Reflex
This testing is recommended for the detection of germline variants associated with severe Hemophilia A . Testing begins with F8 inversion Analysis; if this analysis is negative, F8 Sequence Analysis is performed at an additional charge. Refer to F8 Inversion Analysis and F8 Sequence Analysis for test information. USA test status: This is a laboratory developed test (LDT).
4885
Fibrinogen Disorders Panel
This panel is designed for the detection of germline variants in 3 genes known to cause inherited qualitative or quantitative disorders of fibrinogen. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4860
Fibrinolytic Disorder Panel
This panel is designed for the detection of germline variants in 8 genes and one targeted variant known to cause delayed bleeding due to hyperfibrinolysis. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
3860
Fya/Fyb Genotyping
Genotyping for the Duffy (Fya, Fyb) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
4870
Glanzmann Thrombasthenia Panel
This panel is designed for the detection of germline variants in 2 genes known to cause Glanzmann thrombasthenia.It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4624
Hemoglobin SC Mutation Analysis
Sickle Cell Disease is caused by mutations in the b-globin gene (HBB) and are defined by the presence of hemoglobin S (HbS). Molecular prenatal testing can be offered for pregnancies at increased risk. USA test status: This is a laboratory developed test (LDT). USA test status: This is a laboratory developed test (LDT).
4895
Hereditary Hemorrhagic Telangiectasia Panel
This panel is designed for the detection of germline variants in 6 genes known to cause hereditary hemorrhagic telangiectasia: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4875
Hermansky-Pudlak Syndrome Panel
This panel is designed for the detection of germline variants in 10 genes known to cause Hermansky-Pudlak syndrome. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
2380
HLA Haplotype by STR
A rapid screening test for potential sibling donors for blood & marrow transplant patients. The test must be ordered for the patient and each potential donor. USA test status: This is a laboratory developed test (LDT).
2300
HLA High Resolution Panel by NGS
High Resolution typing for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3,4,5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1 loci by next generation DNA sequencing (NGS). USA test status: This is a laboratory developed test (LDT).
2270
HLA Typing for Narcolepsy
HLA typing for presence of HLA loci associated with narcolepsy. USA test status: This is a laboratory developed test (LDT).
2324
HLA-A High Resolution
High Resolution typing for Class I HLA-A loci. USA test status: This is a laboratory developed test (LDT).
2504
HLA-A Intermediate Resolution
Intermediate Resolution typing for Class I HLA-A loci. USA test status: This is a laboratory developed test (LDT).
2304
HLA-A Low Resolution
Low Resolution typing for Class I HLA-A loci. USA test status: This is a laboratory developed test (LDT).
2279
HLA-A*02:01 Determination
Test for disorders or drug sensitivity associated with HLA-A*02:01 allele. HLA A-High Resolution Typing may be required for confirmation of the allele and an additional charge is incurred. USA test status: This is a laboratory developed test (LDT).
2520
HLA-A,B Intermediate Resolution
Intermediate Resolution typing for Class I HLA-A,B loci. USA test status: This is a laboratory developed test (LDT).
2303
HLA-A,B Low Resolution
Low Resolution typing for Class I HLA-A,B loci. USA test status: This is a laboratory developed test (LDT).
2329
HLA-A,B,C High Resolution
High Resolution typing for Class I HLA-A,B,C, loci. USA test status: This is a laboratory developed test (LDT).
2302
HLA-A,B,C Low Resolution
Low Resolution typing for Class I HLA-A,B,C, loci. USA test status: This is a laboratory developed test (LDT).
2274
HLA-A29 Determination
Test for disease associated with HLA-A29 allele which may be present in Birdshot chorioretinopathy (BSCR). USA test status: This is a laboratory developed test (LDT).
2325
HLA-B High Resolution
High Resolution typing for Class I HLA-B loci. USA test status: This is a laboratory developed test (LDT).
2505
HLA-B Intermediate Resolution
Intermediate Resolution typing for Class I HLA-B loci. USA test status: This is a laboratory developed test (LDT).
2305
HLA-B Low Resolution
Low Resolution typing for Class I HLA-B loci. USA test status: This is a laboratory developed test (LDT).
2276
HLA-B*15:02 Determination
Test for HLA-B*15:02 allele presence or absence for patients that may be prescribed Carbamazepine and Oxcarbazepine to avoid possible adverse reactions. HLA B-High Resolution Typing may be required for confirmation of the allele for an additional fee. USA test status: This is a laboratory developed test (LDT).
2272
HLA-B*57:01 Determination
The HLA-B*57:01 Determination test utilizes a low resolution method. If a possible HLA-B*57:01 allele is identified, HLA B-High Resolution Typing may be required for confirmation of the allele and an additional charge is incurred. USA test status: This is a laboratory developed test (LDT).
2319
HLA-B,DRB1 Verification Typing
Intermediate Resolution typing for HLA-B, DRB1. USA test status: This is a laboratory developed test (LDT).
2271
HLA-B27 Determination
Test for disorders associated with HLA-B27 allele such as Spondyloarthritis. USA test status: This is a laboratory developed test (LDT).
2275
HLA-B51 Determination
Test for disorders associated with HLA-B51 allele such as Behcet Disease (BD). USA test status: This is a laboratory developed test (LDT).
2326
HLA-C High Resolution
High Resolution typing for Class I HLA-C loci. USA test status: This is a laboratory developed test (LDT).
2506
HLA-C Intermediate Resolution
Intermediate Resolution typing for Class I HLA-C loci. USA test status: This is a laboratory developed test (LDT).
2306
HLA-C Low Resolution
Low Resolution typing for Class I HLA-C loci. USA test status: This is a laboratory developed test (LDT).
2323
HLA-DPB1 High Resolution
High Resolution typing for Class II HLA-DPB1 loci. USA test status: This is a laboratory developed test (LDT).
2513
HLA-DPB1/-DPA1 Intermediate Resolution
Intermediate Resolution typing for Class II HLA-DPB1 and DPA1 loci. USA test status: This is a laboratory developed test (LDT).
2318
HLA-DPB1/-DPA1 Low Resolution
Low Resolution typing for Class II HLA-DPB1/DPA1 loci. USA test status: This is a laboratory developed test (LDT).
2277
HLA Typing for Celiac Disease
Test for predisposition to Celiac Disease. USA test status: This is a laboratory developed test (LDT).
2328
HLA-DQB1 High Resolution
High Resolution typing for Class II HLA-DQB1 loci. USA test status: This is a laboratory developed test (LDT).
2308
HLA-DQB1,DQA1 Low Resolution
Low Resolution typing for Class II HLA-DQB1, DQA1 loci. USA test status: This is a laboratory developed test (LDT).
2508
HLA-DQB1,DQA1 Intermediate Resolution
Intermediate Resolution typing for Class II HLA-DQB1, DQA1 loci. USA test status: This is a laboratory developed test (LDT).
2322
HLA-DRB1 High Resolution
High Resolution typing for Class II HLA-DRB1 loci. USA test status: This is a laboratory developed test (LDT).
2507
HLA-DRB1 Intermediate Resolution
Intermediate Resolution typing for Class II HLA-DRB1 loci. USA test status: This is a laboratory developed test (LDT).
2307
HLA-DRB1 Low Resolution
Low Resolution typing for Class II HLA-DRB1 loci. USA test status: This is a laboratory developed test (LDT).
2361
HLA-DRB1 Single Antigen - Disease Association
Identification for HLA disease associated with HLA-DRB1 allele. USA test status: This is a laboratory developed test (LDT).
2553
HLA-DRB1,DQB1,DQA1 Low Resolution
Low Resolution typing for Class II HLA-DRB1,DQB1,DQA1 loci. USA test status: This is a laboratory developed test (LDT).
2321
HLA-DRB3,4,5 Intermediate Resolution
Intermediate Resolution typing for Class II HLA-DRB3,4,5 loci. USA test status: This is a laboratory developed test (LDT).
2122
HLA-DRB3,4,5 Low Resolution
Low Resolution typing for Class II HLA-DRB3,4,5 loci. USA test status: This is a laboratory developed test (LDT).
2377
HLA-KIR Genotyping
DNA based typing to identify the presence of killer cell immunoglobulin-like receptors (KIR) genes. USA test status: This is a laboratory developed test (LDT).
4840
Inherited Thrombocytopenia Panel
This panel is designed for the detection of germline variants in 42 genes known to cause inherited thrombocytopenia. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
3862
Jka/Jkb Genotyping
Genotyping for the Kidd (Jka, Jkb) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3858
Jsa/Jsb Genotyping
Genotyping for the Kell (Jsa, Jsb) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3854
K/k Genotyping
Genotyping for the Kell (K, k) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3856
Kpa/Kpb Genotyping
Genotyping for the Kell (Kpa, Kpb) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3868
Lua/Lub Genotyping
Genotyping for the Lutheran (Lua, Lub) antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
3864
M/N Genotyping
Genotyping for the M and N antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
5250
Neutrophil Antigen Genotyping - HNA-1
This DNA-based typing assay is for the HNA-1 Alloantigen system. USA test status: This is a laboratory developed test (LDT).
5203
Neutrophil Antigen Genotyping - HNA-3
This DNA-based typing assay is for the HNA-3 Alloantigen system. USA test status: This is a laboratory developed test (LDT).
5204
Neutrophil Antigen Genotyping - HNA-4
This DNA-based typing assay is for the HNA-4 Alloantigen system. USA test status: This is a laboratory developed test (LDT).
5205
Neutrophil Antigen Genotyping - HNA-5
This DNA-based typing assay is for the HNA-5 Alloantigen system. USA test status: This is a laboratory developed test (LDT).
5201
Neutrophil Antigen Genotyping Panel
This genotyping panel includes: Neutrophil Antigen Genotyping for HNA-1, 3, 4 and 5. USA test status: This is a laboratory developed test (LDT).
5519
Platelet Antigen Genotyping - HPA-1
Single alloantigen typing for HPA-1. USA test status: This is a laboratory developed test (LDT).
5215
Platelet Antigen Genotyping - HPA-15
Single alloantigen typing for HPA-15. USA test status: This is a laboratory developed test (LDT).
5523
Platelet Antigen Genotyping - HPA-2
Single alloantigen typing for HPA-2. USA test status: This is a laboratory developed test (LDT).
5520
Platelet Antigen Genotyping - HPA-3
Single alloantigen typing for HPA-3. USA test status: This is a laboratory developed test (LDT).
5521
Platelet Antigen Genotyping - HPA-4
Single alloantigen typing for HPA-4. USA test status: This is a laboratory developed test (LDT).
5522
Platelet Antigen Genotyping - HPA-5
Single alloantigen typing for HPA-5. USA test status: This is a laboratory developed test (LDT).
5524
Platelet Antigen Genotyping - HPA-6
Single alloantigen typing for HPA-6. USA test status: This is a laboratory developed test (LDT).
5209
Platelet Antigen Genotyping - HPA-9
Single alloantigen typing for HPA-9. USA test status: This is a laboratory developed test (LDT).
5600
Platelet Antigen Genotyping Panel
This genotyping panel includes 8 alloantigen systems: HPA-1, 2, 3, 4, 5, 6, 9 and 15. USA test status: This is a laboratory developed test (LDT).
4835
Platelet Function Disorder Panel
This panel is designed for the detection of germline variants in 41 genes known to cause inherited platelet dysfunction. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
1024
Prothrombin Gene Mutation (G20210A)
This molecular test evaluates individuals for the prothrombin G20210A variant (F2 c.*97G7>A) associated with increased risk of venous thromboembolism. USA test status: This is a laboratory developed test (LDT).
3530
Red Cell Genotyping Panel
Red Cell Genotyping Panel: 72 PCR-hybridization probes are used in 36 polymerase chain reactions to identify the alleles associated with 44 blood group antigens. USA test status: This is a laboratory developed test (LDT).
3872
RhD Genotyping
Molecular characterization of the the RH genes as an aid to the clinical management of HDFN. USA test status: This is a laboratory developed test (LDT).
3874
RhD Zygosity
This molecular assay is used to determine RHO zygosity/copy number in paternal samples and is valuable for the management of HDFN (Hemolytic Disease of the Fetus and Newborn) related to anti-D. Contact the lmmunohematology Reference Lab for guidance on other uses of this assay. USA test status: This is a laboratory developed test (LDT).
3866
S/s Genotyping
Genotyping for the S and s antigens, used in the context of hemolytic disease of the newborn or fetus. USA test status: This is a laboratory developed test (LDT).
4855
Single Gene Sequence Analysis
Single-gene sequencing is offered for most genes in Versiti's Hematology Genetics menu. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
4970
Targeted Familial Variant Analysis
Targeted genetic analysis is used to determine if a specific familial variant is present. Testing is only available for genes tested by Next Generation sequencing at Versiti Wisconsin, Inc., a sample from an affected relative must be provided a copy of the family member's lab report for the variant being tested. USA test status: This is a laboratory developed test (LDT).
4820
Thrombosis Panel
This panel is designed for the detection of germline variants in 12 genes and 2 targeted variants known to be associated with an increased risk for developing venous thromboembolism. It can be ordered as: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).
1289
VWD Platelet-Type Sequence Analysis
This test for platelet-type VWD provides sequencing of the full coding region (plus 30bp into the introns) of GPIBA. USA test status: This is a laboratory developed test (LDT).
1288
VWD Type 2N Sequence Analysis
Sequence analysis of VWF exons 17-21 and 24-27 detects germline variants associated with type 2N von willebrand disease (VWD). USA test status: This is a laboratory developed test (LDT).
1284
VWF Exon 28 Sequence Analysis (For Type 2M or 2B VWD)
Sequence Analysis of VWF exon 28 detects germline variants associated with type 2B or type 2M von Willebrand disease (VWD). USA test status: This is a laboratory developed test (LDT).